Prestige Consumer Healthcare (PBH) FY2017 results: revenue $882 million, up 9.4% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $882 million for fiscal 2017, the year ended 31 March 2017, up 9.4% on the year before. Net income was $69 million, down 30.5%, and diluted earnings per share $1.30. The figures are the company's own, from the 10-K it filed with the SEC on 13 May 2019.
Revenue
$882 million
+9.4% on the year
FY2010FY2017
Operating margin
23.3%
32.3% a year earlier
FY2010FY2017
Net income
$69 million
-30.5% on the year
FY2010FY2017
Diluted EPS
$1.30
-30.9% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
882
806
715
+9.4%
Cost of revenue
382
339
n/a
+12.6%
Gross profit
500
467
406
+7.1%
Gross margin
56.7%
57.9%
56.8%
Operating income
206
260
208
-21.0%
Operating margin
23.3%
32.3%
29.0%
Interest expense
93.5
85.3
81.3
+9.6%
Pre-tax income
111
157
127
-29.5%
Income tax
41.5
57.3
49.2
-27.6%
Effective tax rate
37.4%
36.4%
38.6%
Net income
69.4
99.9
78.3
-30.5%
Net margin
7.9%
12.4%
11.0%
Diluted EPS
$1.30
$1.88
$1.49
-30.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
149
176
156
-15.7%
Capital expenditure
3.0
3.6
6.1
-16.6%
Free cash flow
146
173
150
-15.7%
Free cash flow margin
16.5%
21.4%
21.0%
Cash from investing
-695
-223
-805
Cash from financing
562
52.1
643
+978.9%
Depreciation and amortisation
25.8
23.7
17.7
+8.9%
Share-based compensation
8.1
10.0
6.9
-18.1%
Buybacks
0.0
n/a
n/a
Dividends paid
n/a
0.0
0.0
Diluted shares, weighted
53m
53m
53m
+0.4%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
823
744
628
+10.5%
Debt
2,194
1,625
1,561
+35.0%
Other liabilities
895
579
453
+54.5%
Total liabilities and equity
3,911
2,949
2,642
+32.6%
Fixed assets
50.6
15.5
13.7
+225.6%
Goodwill
615
360
291
+70.8%
Intangible assets
2,904
2,323
2,135
+25.0%
Cash and equivalents
41.9
27.2
21.3
+53.7%
Receivables
137
95.2
87.9
+43.6%
Inventory
116
91.3
74.0
+26.7%
Other assets
47.7
36.6
19.7
+30.3%
Total assets
3,911
2,949
2,642
+32.6%
10-K for the year ended 31 March 2017, filed 13 May 2019: the filing.